Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $876.78 | 19 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $519.45 | 13 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $218.52 | 4 | $0 (2024) |
| Alkermes, Inc. | $138.81 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $156.75 | 2 | Janssen Pharmaceuticals, Inc ($125.00) |
| 2023 | $230.10 | 4 | Alkermes, Inc. ($103.43) |
| 2022 | $345.93 | 7 | Janssen Pharmaceuticals, Inc ($203.72) |
| 2021 | $144.00 | 6 | Janssen Pharmaceuticals, Inc ($144.00) |
All Payment Transactions
19 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neuroscience | ||||||
| 04/03/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $31.75 | General |
| Category: Neuropsychiatry | ||||||
| 09/12/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Neuroscience | ||||||
| 08/17/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $79.94 | General |
| Category: Neuropsychiatry | ||||||
| 07/13/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $103.43 | General |
| Category: CNS | ||||||
| 04/05/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: Neuroscience | ||||||
| 10/26/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $58.20 | General |
| Category: Neuropsychiatry | ||||||
| 10/19/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neuroscience | ||||||
| 07/07/2022 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $35.38 | General |
| Category: CNS | ||||||
| 06/29/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $29.37 | General |
| Category: Neuroscience | ||||||
| 06/21/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | Cash or cash equivalent | $48.63 | General |
| Category: Neuropsychiatry | ||||||
| 05/10/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: Neuroscience | ||||||
| 03/16/2022 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Neuroscience | ||||||
| 12/23/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: Neuroscience | ||||||
| 10/06/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $27.31 | General |
| Category: Neuroscience | ||||||
| 05/27/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: Neuroscience | ||||||
| 05/04/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Neuroscience | ||||||
| 04/06/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA, SPRAVATO | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Neuroscience | ||||||
| 03/03/2021 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug), INVEGA TRINZA | Food and Beverage | In-kind items and services | $24.18 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 27 | 55 | $15,694 | $4,457 |
| 2022 | 3 | 82 | 169 | $37,545 | $8,968 |
| 2021 | 3 | 118 | 230 | $45,706 | $12,900 |
| 2020 | 2 | 58 | 151 | $28,468 | $8,521 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 16 | 36 | $9,452 | $2,374 | 25.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 19 | $6,242 | $2,082 | 33.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 41 | 89 | $23,368 | $5,312 | 22.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 40 | $7,236 | $1,978 | 27.3% |
| 90833 | Psychotherapy with evaluation and management visit, 30 minutes | Office | 2022 | 19 | 40 | $6,942 | $1,677 | 24.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 52 | 109 | $25,915 | $8,512 | 32.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 33 | 61 | $9,378 | $2,537 | 27.1% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 33 | 60 | $10,413 | $1,850 | 17.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 46 | 138 | $26,771 | $8,034 | 30.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 12 | 13 | $1,696 | $487.02 | 28.7% |
About Walt Hutton, NP
Walt Hutton, NP is a Psychiatric/Mental Health healthcare provider based in Flagstaff, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/28/2017. The National Provider Identifier (NPI) number assigned to this provider is 1336658731.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Walt Hutton, NP has received a total of $876.78 in payments from pharmaceutical and medical device companies, with $156.75 received in 2024. These payments were reported across 19 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($876.78).
As a Medicare-enrolled provider, Hutton has provided services to 285 Medicare beneficiaries, totaling 605 services with total Medicare billing of $34,845. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Psychiatric/Mental Health
- Location Flagstaff, AZ
- Active Since 09/28/2017
- Last Updated 04/03/2018
- Taxonomy Code 363LP0808X
- Entity Type Individual
- NPI Number 1336658731
Products in Payments
- INVEGA SUSTENNA (Drug) $501.43
- INGREZZA (Drug) $218.52
- LYBALVI (Drug) $138.81
- SPRAVATO (Drug) $18.02
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatric/Mental Health Doctors in Flagstaff
Mr. Phillip Dubravcic, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $1,904
Rachel Josefchuk, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $875.22
Mrs. Amy Duschinski, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $368.76
Melanie Platt
Psychiatric/Mental Health — Payments: $257.05
Joan Moore, Pmhnp, PMHNP
Psychiatric/Mental Health — Payments: $173.89
Jared Bennett, Pmhnp-Bc, PMHNP-BC
Psychiatric/Mental Health — Payments: $37.52